NRx Pharmaceuticals’ (NRXP) Buy Rating Reiterated at D. Boral Capital
D. Boral Capital reaffirmed their buy rating on shares of NRx Pharmaceuticals (NASDAQ:NRXP – Free Report) in a report published on Monday,Benzinga reports. The firm currently has a $31.00 price target on the stock. NRXP has been the topic of several other reports. Ascendiant Capital Markets upped their target price on shares of NRx Pharmaceuticals […]
D. Boral Capital reaffirmed their buy rating on shares of NRx Pharmaceuticals (NASDAQ:NRXP – Free Report) in a report published on Monday,Benzinga reports. The firm currently has a $31.00 price target on the stock. NRXP has been the topic of several other reports. Ascendiant Capital Markets upped their target price on shares of NRx Pharmaceuticals […]
